Current Protein Identity:P58335 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1SHT Crystal Structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor Deposited 2004-02-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain X 38–217(180 aa) Fragment:VWA domain
Not recorded ACT ACETATE ION × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8K, magnesium acetate, sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.81 Å R-free 0.186
1SHU Crystal Structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor Deposited 2004-02-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain X 38–218(181 aa) Fragment:VWA domain
Not recorded MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;PEG3350, magnesium chloride, bis-tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.50 Å R-free 0.215
1T6B Crystal structure of B. anthracis Protective Antigen complexed with human Anthrax toxin receptor Deposited 2004-05-05 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Y 35–212(178 aa) Fragment:A/I domain
Not recorded CA CALCIUM ION × 2 NA SODIUM ION × 2 PG4 TETRAETHYLENE GLYCOL × 1 MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9;300 K;CHES buffer, PEG400, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 300K
Resolution 2.50 Å R-free 0.266
1TZN Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor Deposited 2004-07-10 Assembly 1 Protein heterocomplex Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain a 38–218(181 aa) Fragment:VWA domain
Chain b 38–218(181 aa) Fragment:VWA domain
Chain c 38–218(181 aa) Fragment:VWA domain
Chain d 38–218(181 aa) Fragment:VWA domain
Chain e 38–218(181 aa) Fragment:VWA domain
Chain f 38–218(181 aa) Fragment:VWA domain
Chain o 38–218(181 aa) Fragment:VWA domain
Not recorded CA CALCIUM ION × 14 MG MAGNESIUM ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 8000, sodium chloride, Tris, magnesium chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 4.30 Å R-free 0.330
1TZN Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor Deposited 2004-07-10 Assembly 2 Protein heterocomplex Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain g 38–218(181 aa) Fragment:VWA domain
Chain h 38–218(181 aa) Fragment:VWA domain
Chain i 38–218(181 aa) Fragment:VWA domain
Chain j 38–218(181 aa) Fragment:VWA domain
Chain k 38–218(181 aa) Fragment:VWA domain
Chain l 38–218(181 aa) Fragment:VWA domain
Chain m 38–218(181 aa) Fragment:VWA domain
Not recorded CA CALCIUM ION × 14 MG MAGNESIUM ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 8000, sodium chloride, Tris, magnesium chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 4.30 Å R-free 0.330
1TZN Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor Deposited 2004-07-10 Assembly 3 Protein heterocomplex Heteromer;Protein × 28 PDB declaration: 28-meric(28) Consistent with protein count
Chain a 38–218(181 aa) Fragment:VWA domain
Chain b 38–218(181 aa) Fragment:VWA domain
Chain c 38–218(181 aa) Fragment:VWA domain
Chain d 38–218(181 aa) Fragment:VWA domain
Chain e 38–218(181 aa) Fragment:VWA domain
Chain f 38–218(181 aa) Fragment:VWA domain
Chain g 38–218(181 aa) Fragment:VWA domain
Chain h 38–218(181 aa) Fragment:VWA domain
Chain i 38–218(181 aa) Fragment:VWA domain
Chain j 38–218(181 aa) Fragment:VWA domain
Chain k 38–218(181 aa) Fragment:VWA domain
Chain l 38–218(181 aa) Fragment:VWA domain
Chain m 38–218(181 aa) Fragment:VWA domain
Chain o 38–218(181 aa) Fragment:VWA domain
Not recorded CA CALCIUM ION × 28 MG MAGNESIUM ION × 14 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 8000, sodium chloride, Tris, magnesium chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 4.30 Å R-free 0.330
1TZN Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor Deposited 2004-07-10 Assembly 4 Protein heterocomplex Heteromer;Protein × 28 PDB declaration: 28-meric(28) Consistent with protein count
Chain a 38–218(181 aa) Fragment:VWA domain
Chain b 38–218(181 aa) Fragment:VWA domain
Chain c 38–218(181 aa) Fragment:VWA domain
Chain d 38–218(181 aa) Fragment:VWA domain
Chain e 38–218(181 aa) Fragment:VWA domain
Chain f 38–218(181 aa) Fragment:VWA domain
Chain g 38–218(181 aa) Fragment:VWA domain
Chain h 38–218(181 aa) Fragment:VWA domain
Chain i 38–218(181 aa) Fragment:VWA domain
Chain j 38–218(181 aa) Fragment:VWA domain
Chain k 38–218(181 aa) Fragment:VWA domain
Chain l 38–218(181 aa) Fragment:VWA domain
Chain m 38–218(181 aa) Fragment:VWA domain
Chain o 38–218(181 aa) Fragment:VWA domain
Not recorded CA CALCIUM ION × 28 MG MAGNESIUM ION × 14 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 8000, sodium chloride, Tris, magnesium chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 4.30 Å R-free 0.330
1TZN Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor Deposited 2004-07-10 Assembly 5 Protein heterocomplex Heteromer;Protein × 28 PDB declaration: 28-meric(28) Consistent with protein count
Chain a 38–218(181 aa) Fragment:VWA domain
Chain b 38–218(181 aa) Fragment:VWA domain
Chain c 38–218(181 aa) Fragment:VWA domain
Chain d 38–218(181 aa) Fragment:VWA domain
Chain e 38–218(181 aa) Fragment:VWA domain
Chain f 38–218(181 aa) Fragment:VWA domain
Chain g 38–218(181 aa) Fragment:VWA domain
Chain h 38–218(181 aa) Fragment:VWA domain
Chain i 38–218(181 aa) Fragment:VWA domain
Chain j 38–218(181 aa) Fragment:VWA domain
Chain k 38–218(181 aa) Fragment:VWA domain
Chain l 38–218(181 aa) Fragment:VWA domain
Chain m 38–218(181 aa) Fragment:VWA domain
Chain o 38–218(181 aa) Fragment:VWA domain
Not recorded CA CALCIUM ION × 28 MG MAGNESIUM ION × 14 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;PEG 8000, sodium chloride, Tris, magnesium chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 4.30 Å R-free 0.330
7N1O The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone Deposited 2021-05-27 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 40–217(178 aa)
Mutation:1TEL: R41A,D46G,V112E,K122A,vWa: R49A,C175A,V112A,K112A MG MAGNESIUM ION × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.7;298 K;100 mM BisTris, 3.0 M NaCl
Resolution 2.77 Å R-free 0.228
8FT6 The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Ala-Ala linker variant, SUMO tag-free preparation. Deposited 2023-01-11 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 40–217(178 aa)
Mutation:R14A,V77E,K87A,R89A,R91A,A225V CIT CITRIC ACID × 1 IOD IODIDE ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.2M Ammonium citrate tribasic, 20% w/v PEG 3350
Resolution 2.62 Å R-free 0.234
8FT8 The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Thr-Val linker variant, SUMO tag-free preparation Deposited 2023-01-11 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 40–217(178 aa)
Mutation:R14A,V77E,K87A,R89A,R91T,A92V,A225V GOL GLYCEROL × 1 CL CHLORIDE ION × 3 K POTASSIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.1M HEPES, 2.0M ammonium sulfate
Resolution 1.60 Å R-free 0.204
8FZ4 The von Willebrand factor A domain of Anthrax toxin receptor 2 Deposited 2023-01-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 37–217(181 aa)
Mutation:P37G, C39A, C175A MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9.5;298 K;1.2 uL of 20 mg/mL protein in 12.5 mM Tris pH 8.8, 200mM KCl, 10mM MgCl2 combined with 1.2 uL of 0.1 M Glycine pH 9.5, 24% PEG 3350
Resolution 2.19 Å R-free 0.256
8FZ4 The von Willebrand factor A domain of Anthrax toxin receptor 2 Deposited 2023-01-27 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 37–217(181 aa)
Mutation:P37G, C39A, C175A MG MAGNESIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9.5;298 K;1.2 uL of 20 mg/mL protein in 12.5 mM Tris pH 8.8, 200mM KCl, 10mM MgCl2 combined with 1.2 uL of 0.1 M Glycine pH 9.5, 24% PEG 3350
Resolution 2.19 Å R-free 0.256
8FZU The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Thr-Val linker variant, Expressed with SUMO tag Deposited 2023-01-30 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 39–217(179 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.1M HEPES 2.0M ammonium sulfate
Resolution 1.90 Å R-free 0.266
8FZU The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Thr-Val linker variant, Expressed with SUMO tag Deposited 2023-01-30 Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 39–217(179 aa)
Not recorded K POTASSIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.1M HEPES 2.0M ammonium sulfate
Resolution 1.90 Å R-free 0.266
8FZU The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Thr-Val linker variant, Expressed with SUMO tag Deposited 2023-01-30 Assembly 3 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 39–217(179 aa)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.1M HEPES 2.0M ammonium sulfate
Resolution 1.90 Å R-free 0.266
8FZV The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Ala-Ala linker variant, expressed with SUMO tag Deposited 2023-01-30 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 40–217(178 aa)
Not recorded MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;298 K;100 mM sodium acetate, pH 4.6, 2.0 M sodium formate
Resolution 3.29 Å R-free 0.314
8FZV The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Ala-Ala linker variant, expressed with SUMO tag Deposited 2023-01-30 Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 40–217(178 aa)
Not recorded UNX UNKNOWN LIGAND × 32 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;298 K;100 mM sodium acetate, pH 4.6, 2.0 M sodium formate
Resolution 3.29 Å R-free 0.314
8FZV The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Ala-Ala linker variant, expressed with SUMO tag Deposited 2023-01-30 Assembly 3 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 40–217(178 aa)
Not recorded UNX UNKNOWN LIGAND × 58 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;298 K;100 mM sodium acetate, pH 4.6, 2.0 M sodium formate
Resolution 3.29 Å R-free 0.314
9DOC The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Thr-Val linker variant, at 1.2 Angstrom resolution Deposited 2024-09-18 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 43–217(175 aa) Fragment:von Willebrand factor A domain of CMG2
Mutation:TELSAM: R80S,V112E (Uniprot numbering),vWA: C175A (Uniprot numbering) GOL GLYCEROL × 1 PO4 PHOSPHATE ION × 2 MG MAGNESIUM ION × 7 NA SODIUM ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.25;298 K;100 mM Bis-Tris, pH 7.25, 1350 mM Sodium Potassium Phosphate
Resolution 1.19 Å R-free 0.197
9RT2 NetF - ANTXR2 structure (C4) Deposited 2025-07-01 Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain C1 34–318(285 aa)
Chain C2 34–318(285 aa)
Chain C3 34–318(285 aa)
Chain C4 34–318(285 aa)
Mutation:deleted TM and cytoplasmic domains Mutation:deleted TM and cytoplasmic domains Mutation:deleted TM and cytoplasmic domains Mutation:deleted TM and cytoplasmic domains No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.60 Å
9RT4 NetF - ANTXR2 local refinement focused Deposited 2025-07-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C1 34–318(285 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.60 Å
9YKB The von Willebrand factor A domain of human capillary morphogenesis gene II, fused to the 1TEL crystallization chaperone, Ala-Val linker variant, expressed with SUMO tag. Deposited 2025-10-06 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 40–217(178 aa)
Mutation:R4A,V67E,K77A,R81A,A82V,C215A MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.1 M BisTrisPropane, 1.5M Ammonium Sulfate
Resolution 2.50 Å R-free 0.194
9YKB The von Willebrand factor A domain of human capillary morphogenesis gene II, fused to the 1TEL crystallization chaperone, Ala-Val linker variant, expressed with SUMO tag. Deposited 2025-10-06 Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 40–217(178 aa)
Mutation:R4A,V67E,K77A,R81A,A82V,C215A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.1 M BisTrisPropane, 1.5M Ammonium Sulfate
Resolution 2.50 Å R-free 0.194
9YKB The von Willebrand factor A domain of human capillary morphogenesis gene II, fused to the 1TEL crystallization chaperone, Ala-Val linker variant, expressed with SUMO tag. Deposited 2025-10-06 Assembly 3 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 40–217(178 aa)
Mutation:R4A,V67E,K77A,R81A,A82V,C215A MG MAGNESIUM ION × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;0.1 M BisTrisPropane, 1.5M Ammonium Sulfate
Resolution 2.50 Å R-free 0.194